Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma

被引:2
|
作者
Lukesova, S. [2 ,6 ]
Kopecky, O. [1 ,2 ,6 ]
Vroblova, V. [3 ]
Hlavkova, D. [3 ]
Andrys, C. [3 ]
Moravek, P. [4 ]
Cermakova, E. [5 ]
机构
[1] Charles Univ Prague, Fac Med, Hradec Kralove 50005, Czech Republic
[2] Univ Teaching Hosp, Dept Internal Med 2, Hradec Kralove 50005, Czech Republic
[3] Univ Teaching Hosp, Inst Clin Immunol & Allergol, Hradec Kralove 50005, Czech Republic
[4] Univ Teaching Hosp, Dept Urol, Hradec Kralove 50005, Czech Republic
[5] Univ Teaching Hosp, Comp Technol Ctr, Hradec Kralove 50005, Czech Republic
[6] Dist Hosp Ndchod, Dept Oncol, Nachod, Czech Republic
关键词
renal cell carcinoma; angiogenin; PDGF; MCP-1; protein array method;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using the protein array method we determined the serum levels of a number of angiogenic factors. We identified serum levels of angiogenin, PDGF and MCP-1 (CCL2 chemokine) in serum of 32 patients with RCC, and 14 healthy volunteers by means of antibody array analysis. The patients were divided into three groups according to their disease stages (I+II, III, and IV). We found significant differences between the controls and patients with RCC both pre-operatively and post-operatively in angiogenin, PDGF and MCP-1 serum levels. The increase in angiogenin, PDGF and MCP-1 lasted in patients with RCC stages I-III even without metastases eight weeks post-operatively. The patients with stage IV RCC showed disturbed production of PDGF and MCP-1. Protein array analysis is a powerful tool for the identification of large numbers of trace proteins. Multiplex antibody array is able to provide data more precisely reflecting the nature of pathological processes.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [31] CHANGES IN SERUM HAPTOGLOBIN IN PATIENTS WITH RENAL CELL-CARCINOMA
    SASAKI, T
    MASUDA, F
    ARAI, Y
    KUDO, K
    JAPANESE JOURNAL OF UROLOGY, 1977, 68 (01): : 50 - 58
  • [32] Soluble Fas in serum from patients with renal cell carcinoma
    Nonomura, N
    Nishinura, K
    Ono, Y
    Fukui, T
    Harada, Y
    Takaha, N
    Takahara, S
    Okuyama, A
    UROLOGY, 2000, 55 (01) : 151 - 155
  • [33] Decreased serum adiponectin levels in patients with renal cell carcinoma
    Horiguchi, Akio
    Ito, Keiichi
    Sumitomo, Makoto
    Kimura, Fumihiro
    Asano, Tomohiko
    Hayakawa, Masamichi
    JOURNAL OF UROLOGY, 2008, 179 (04): : 137 - 137
  • [34] SERUM BASIC FETOPROTEIN IN PATIENTS WITH RENAL-CELL CARCINOMA
    GOHJI, K
    ISHII, M
    NAGATA, H
    MATSUMOTO, O
    KAMIDONO, S
    CANCER, 1990, 65 (06) : 1405 - 1411
  • [35] Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma
    Kimura, M
    Tomita, Y
    Imai, T
    Saito, T
    Katagiri, A
    Ohara-Mikami, Y
    Matsudo, T
    Takahashi, K
    CANCER, 2001, 92 (08) : 2072 - 2075
  • [36] Serum protein profiling to identify biomarkers for small renal cell carcinoma
    Xu, Gang
    Hou, Chen-Rui
    Jiang, Hao-Wen
    Xiang, Cui-Qin
    Shi, Nong
    Yuan, Hai-Chuan
    Ding, Qiang
    Zhang, Yuan-Fang
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2010, 47 (04): : 211 - 218
  • [37] INNOVATIVE DIAGNOSTIC APPROACHES: SERUM PROTEIN MARKERS IN RENAL CELL CARCINOMA
    Elizabeth, Davis Laura
    Betty, Wang
    Eran, Maina
    Rebecca, Campbell
    Mohit, Sindhani
    Christopher, Wee
    Christopher, Weight
    Phillip, Abbosh
    Steven, Campbell
    Robert, Abouassaly
    Adam, Calaway
    Pedro, Barata
    Laura, Bukavina
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [38] Identification of two new serum protein profiles for renal cell carcinoma
    Engwegen, Judith Y. M. N.
    Mehra, Niven
    Haanen, John B. A. G.
    Schellens, Jan H. M.
    Voest, Emile E.
    Beijnen, Jos H.
    ONCOLOGY REPORTS, 2009, 22 (02) : 401 - 408
  • [39] Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
    Murphy, Danielle A.
    Rini, Brian I.
    Escudier, Bernard
    Motzer, Robert J.
    Wang, Panpan
    Li, Sherry
    Williams, J. Andrew
    Tarazi, Jamal C.
    Martini, Jean-Francois
    FUTURE ONCOLOGY, 2020, 16 (17) : 1199 - 1210
  • [40] SERUM LEVEL OF IMMUNOSUPPRESSIVE ACIDIC PROTEIN IN HEMODIALYSIS-PATIENTS WITH OR WITHOUT RENAL-CELL CARCINOMA
    SASAGAWA, I
    NAKADA, T
    KUBOTA, Y
    SUZUKI, H
    SAWAMURA, T
    BRITISH JOURNAL OF UROLOGY, 1994, 73 (04): : 355 - 357